Company profile: NeoChord
1.1 - Company Overview
Company description
- Provider of devices and services for mitral valve repair on a beating heart, including the NeoChord DS1000 System for echo-guided restoration of damaged mitral valve chords through a small incision; NeoChord ConsultConnect and ConnectCARD consultation services for delivery of artificial chordae tendineae to aid treatment of mitral insufficiency; and the Transcatheter Transseptal NeoChord NeXuS for MRI safety under specific conditions post-treatment with NeoChord devices.
Products and services
- NeoChord DS1000 System: Echo-guided device that performs mitral valve repair through a small incision on a beating heart by restoring damaged mitral valve chords during the procedure
- Transcatheter Transseptal NeoChord NeXuS: MRI-conditional system for patients requiring MRI after treatment with NeoChord devices, ensuring safety under specific MRI conditions in transcatheter transseptal contexts
- NeoChord ConsultConnect and ConnectCARD: Mitral insufficiency-focused consultation service that assists delivery of artificial chordae tendineae to aid treatment of mitral insufficiency in appropriate patients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NeoChord
Health Diagnostic Laboratory
HQ: United States
Website
- Description: Provider of laboratory medicine expertise; founded in 2008, HDL Inc. is the parent of HDL Europe and is led by founders with over 70 years of experience holding key positions at renowned institutions including the Mayo Clinic, Indiana University Medical Center, and Wako Diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Health Diagnostic Laboratory company profile →
Advanced Circulatory
HQ: United States
Website
- Description: Provider of intrathoracic pressure regulation products designed to help restore life and improve the quality of life for patients experiencing cardiac arrest, low blood pressure, and head injury. Serves military, emergency medical services, and hospital markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Circulatory company profile →
Navilyst Medical
HQ: United States
Website
- Description: Provider of medical devices focused on fluid management and vascular access, formed from Boston Scientific’s Fluid Management and Vascular Access units. Offers devices including PASV Valve Technology, an expanded line of Xcela Power Injectable PICCs, and NAMIC fluid management products; develops, manufactures, and markets these solutions. Headquartered in Marlborough, MA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navilyst Medical company profile →
Huyabio
HQ: United States
Website
- Description: Provider of novel biopharmaceutical product opportunities, including HBI-8000, an oral class I selective HDAC inhibitor for cancers; HBI-3000, a multi-ion channel blocker for atrial fibrillation; HBI-2376, an SHP2 inhibitor for solid tumors; HBI-ONC, an epigenetic inhibitor for MDS/AML; and HBI-3800, a small molecule to regenerate cardiac muscle damaged by ischemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Huyabio company profile →
enVVeno Medical
HQ: United States
Website
- Description: Provider of bioprosthetic devices for cardiovascular surgeries, including VenoValve, a surgically implanted one-way valve to restore proper blood flow in the femoral vein for patients with deep venous Chronic Venous Insufficiency (CVI), and enVVe, a non-surgical, transcatheter-based replacement venous valve for minimally invasive treatment of CVI in the deep veins of the leg.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full enVVeno Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NeoChord
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NeoChord
2.2 - Growth funds investing in similar companies to NeoChord
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NeoChord
4.2 - Public trading comparable groups for NeoChord
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →